Cosmos Pharmaceutical
3349.TRetail Trade
Financials · Consolidated
| Fiscal year ended | 2026-05 | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|---|
| Revenue | ¥1.10T | ¥1.01T | ¥965.0bn | ¥827.7bn | ¥755.4bn | ¥726.4bn |
| Operating income | ¥42.4bn | ¥40.4bn | ¥31.5bn | ¥30.1bn | ¥29.8bn | ¥33.1bn |
| Ordinary income | ¥44.6bn | ¥43.2bn | ¥34.3bn | ¥33.1bn | ¥32.9bn | ¥35.8bn |
| Net income (owners) | ¥32.0bn | ¥31.0bn | ¥24.5bn | ¥23.8bn | ¥23.2bn | ¥27.2bn |
| Total assets | ¥596.5bn | ¥524.8bn | ¥476.5bn | ¥421.0bn | ¥363.1bn | ¥341.3bn |
| Net assets / equity | ¥283.7bn | ¥257.5bn | ¥231.4bn | ¥211.1bn | ¥190.5bn | ¥170.6bn |
| Operating cash flow | ¥58.8bn | ¥52.5bn | ¥55.2bn | ¥54.4bn | ¥32.2bn | ¥27.9bn |
| EPS (basic) | ¥404.33 | ¥390.86 | ¥308.61r | ¥600.96 | ¥584.76 | ¥685.8 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-06-01 → 2026-05-31 | Annual | 197 figures · EDINET |
| 2025-06-01 → 2025-11-30 | Half-year | 67 figures · EDINET |
| 2024-06-01 → 2025-05-31 | Annual | 196 figures · EDINET |
| 2024-06-01 → 2024-11-30 | Half-year | 67 figures · EDINET |
| 2023-06-01 → 2024-05-31 | Annual | 197 figures · EDINET |
| 2023-06-01 → 2024-02-29 | Quarterly Q3 | 45 figures · EDINET |
| 2023-06-01 → 2023-11-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-06-01 → 2023-08-31 | Quarterly Q1 | 43 figures · EDINET |
| 2022-06-01 → 2023-05-31 | Annual | 197 figures · EDINET |
| 2022-06-01 → 2023-02-28 | Quarterly Q3 | 45 figures · EDINET |
| 2022-06-01 → 2022-11-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-06-01 → 2022-08-31 | Quarterly Q1 | 43 figures · EDINET |
| 2021-06-01 → 2022-05-31 | Annual | 197 figures · EDINET |
22 more reports are still being processed.